Form: SC 13D

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

July 7, 2014

 

Exhibit 99.1


JOINT FILING AGREEMENT

The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13D jointly on behalf of each such party.

Date: July 7, 2014
     
 
MAYNE PHARMA VENTURES PTY LTD
     
  /s/ Mark Cansdale  
 
Mark Cansdale, Secretary
 
     
 
MAYNE PHARMA INTERNATIONAL PTY LTD
     
  /s/ Mark Cansdale  
 
Mark Cansdale, Secretary
 
     
 
MAYNE PHARMA GROUP LTD
     
  /s/ Mark Cansdale  
 
Mark Cansdale, Secretary